LY01021

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY01021, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART) [Phase 2]

See pricing